Dyslipidemias and the primary prevention of cardiovascular disease: Analysis of the FAMUS primary care register

Canadian Journal of Cardiology

Volumn 16, Issue 7, 2000, Pages 879-885

  Xhignesse, M ^a   Laplante, P ^a   Niyonsenga, T ^a   Courteau, J ^a   Grant, A M ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

Lipids; Pharmacology; Prevention; Registries; Risk factors

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIMARY PREVENTION; RISK FACTOR;

ADULT; ANTILIPEMIC AGENTS; CARDIOVASCULAR DISEASES; FAMILY PRACTICE; FEMALE; HUMANS; HYPERLIPIDEMIAS; LIPIDS; MALE; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; PRESCRIPTIONS, DRUG; PRIMARY HEALTH CARE; PRIMARY PREVENTION; QUEBEC; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0033891334     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Lowering the blood total cholesterol level to prevent coronary heart disease
2. Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials
3. An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence
4. Cholesterol lowering and mortality: The importance of considering initial level of risk
5. Effect of statins on risk of coronary disease: A meta-analysis of randomized controlled trials
6. Congres sur le Consensus canadien sur le cholesterol: Rapport Final
7. The periodic health examination, 1993 update: 2. Lowering the blood total cholesterol level to prevent coronary heart disease
8. Rationale for and outline of the recommendations of the Working Group on Hypercholesterolemia and Other Dyslipidemias: Interim report
9. Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias
10. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
11. AHA consensus panel statement. Preventing heart attack and death in patients with coronary disease. The Secondary Prevention Panel
12. Primary prevention of coronary heart disease: Guidance from Framingham: A statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association
13. Management of the postmyocardial infarction patient: A consensus report - Revision of 1991 CCS guidelines
14. Cardiovascular risk management among 1806 low risk patients in a primary care setting
15. Cholesterol measurement and treatment in community practices
16. A comparison of primary versus secondary cardiovascular disease prevention in an academic family practice
17. Current physician screening and treatment of hypercholesterolemic patients
18. Implementation of a province-wide computerized network in Quebec: The FAMUS Project
19. The TEAM evaluation approach to Project FAMUS, a pan-Canadian risk register for primary care
20. Habitudes de traitement de l'hypertension en 1996: Donnees du registre quebecois FAMUS
21. Antiplatelet and lipid-lowering therapies for the secondary prevention of cardiovascular disease: Are we doing enough?
22. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
23. Assessing the quality of data entry in a computerized medical records system
24. Les effectifs medicaux au Quebec - Situation de 1972 a 1992 et projections pour 1997
25. Estimating the benefits of modifying risk factors of cardiovascular disease: A comparison of primary vs secondary prevention